Stable EBITDA and cash flow despite a 23% drop in managed lives, with the lowest churn in four years and strong cost discipline. New regional products and HMOs are gaining traction, while operational improvements and commercial realignment support future growth.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.